A multicenter phase 1/2 trial evaluated the acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine over 48 weeks in adolescents with HIV-1, focusing on patient-reported pain,...
In February 2025, the Department of Health and Human Services announced a plan to overhaul its functions and consolidate resources. Since that announcement, workforce cuts, legal battles, and partial...
A new analysis of US claims data examined preexposure prophylaxis prescribing patterns among commercially insured adolescents and young adults at increased risk for HIV, offering clinicians insights into...
A new study examined the relationship between the use of opioids and increased risk for hospitalizations due to serious infections among rheumatoid arthritis patients.
In England, children and young people faced sharply higher risks of venous thromboembolism, thrombocytopenia, myocarditis or pericarditis, and systemic inflammatory conditions after a first COVID-19...
In this respiratory disease roundup, researchers highlight the efficacy of clesrovimab in preventing respiratory syncytial virus infections in infants, the influenza vaccine's updated formulation this virus...
